Antibiotic treatment in patients with altered pathophysiological pathways

Area of Science:

• Pharmacology
• Geriatrics
• Nephrology
• Hepatology

Background:

• Antibiotic management requires careful consideration in elderly patients due to immunosenescence and altered pharmacokinetics.
• Renal and liver failure significantly impact antibiotic behavior, often leading to suboptimal therapeutic approaches.
• Newer antibiotic classes, including Teicoplanin, Carbapenems, and Fluoroquinolones, necessitate specific pharmacokinetic evaluations in these patient populations.

Purpose of the Study:

• To review the pharmacokinetics of antibiotics in physiological (senescence) and pathological (renal/liver failure) conditions.
• To highlight the challenges in antibiotic management for elderly patients and those with organ dysfunction.
• To focus on the pharmacokinetic profiles of newer antibiotic agents.

Main Methods:

• Literature review of antibiotic pharmacokinetics.
• Analysis of physiological and pathological factors affecting drug disposition.
• Focus on specific antibiotic classes: Teicoplanin, Carbapenems, Fluoroquinolones.

Main Results:

• Elderly patients exhibit kinetic modifications and immunosenescence impacting antibiotic efficacy.
• Renal failure necessitates precise dosage adjustments, especially concerning hemodialysis.
• Liver failure presents complex pharmacokinetic alterations that are frequently underestimated.
• Newer antibiotics show varied pharmacokinetic profiles in compromised organ systems.

Conclusions:

• Optimizing antibiotic therapy in elderly and organ-compromised patients requires a thorough understanding of pharmacokinetics.
• Individualized dosing strategies are essential to ensure efficacy and minimize toxicity.
• Further research into the pharmacokinetics of novel antibiotics in specific patient groups is warranted.